The UK stands at a critical juncture. Investing in preventative health is no longer a "nice to have," but a profound economic and social priority.

Deloitte recently published a key report, "The Shift to Prevention: Realising the Socio-Economic Potential," which reveals that increasing prevention spend from 6% to 10% could lead to £42bn in healthcare system savings over the next decade.

For ABHI members, this shift represents a fundamental change in how HealthTech, and specifically diagnostics, will be valued and integrated into the NHS. If the UK is to unlock the £8 return for every £1 spent on prevention, the role of early detection, remote monitoring, and rapid diagnostics is paramount.

Why attend? In this session, Deloitte’s lead authors will present their findings and engage in a discussion specifically focused on the HealthTech ecosystem. We will explore:

• The £42bn Opportunity: How a preventative-first model changes the funding landscape.
• The Role of Diagnostics: Why early intervention is the engine of prevention.
• Reform of Appraisal Models: Why current value-assessment methods often fail prevention technologies and what needs to change.
• New Ecosystems: How diagnostics companies can position themselves as partners in a "health promotion" rather than "sickness treatment" model.

This event is designed for leadership, market access, and government affairs teams within ABHI member companies, particularly those involved in diagnostics, digital health, and screening technologies.

REGISTER HERE.